Clinical outcomes and timing on the combination of focal radiation therapy and immunotherapy for the treatment of brain metastases.

Front Immunol · 2023 · PMC10616465 · PMID 37915576

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

One-year iPFS did not reach statistical significance but showed a tendency to be superior when delivering both treatments concurrently (within a month), compared to SRT delivered before or after ICI (49.6% vs 24.1% and 34.2%, respectively, p=0.09).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.